Drospirenone And Ethinyl Estradiol
Generic Name: drospirenone and ethinyl estradiol
Brand Names:
Ocella
Drospirenone and ethinyl estradiol is an oral contraceptive regimen consisting of 28 film-coated tablets for pregnancy prevention.
Overview
Drospirenone and ethinyl estradiol is an oral contraceptive regimen consisting of 28 film-coated tablets for pregnancy prevention.
Uses
Indicated for use by females of reproductive potential to prevent pregnancy.
Dosage
Take one tablet daily by mouth at the same time every day. Tablets must be taken in the order directed on the blister pack.
Side Effects
Most frequent include premenstrual syndrome (13.2%), headache/migraine (10.7%), breast pain/tenderness/discomfort (8.3%).
Interactions
Enzyme inducers may decrease effectiveness. Potential interactions with multiple medication classes documented.
Warnings
BOXED WARNING: Women over 35 years old who smoke should not use this product due to cardiovascular risks. Multiple warnings covering vascular risks, hyperkalemia potential, liver disease, and hypertension concerns. Contraindicated in females with renal impairment, adrenal insufficiency, thrombotic disease risks, and hepatic disease.
Pregnancy
Epidemiologic studies found no increased risk of genital or non-genital birth defects following early exposure.
Frequently Asked Questions
What is Drospirenone And Ethinyl Estradiol used for?▼
Indicated for use by females of reproductive potential to prevent pregnancy.
What are the side effects of Drospirenone And Ethinyl Estradiol?▼
Most frequent include premenstrual syndrome (13.2%), headache/migraine (10.7%), breast pain/tenderness/discomfort (8.3%).
Can I take Drospirenone And Ethinyl Estradiol during pregnancy?▼
Epidemiologic studies found no increased risk of genital or non-genital birth defects following early exposure.
What are the important warnings for Drospirenone And Ethinyl Estradiol?▼
BOXED WARNING: Women over 35 years old who smoke should not use this product due to cardiovascular risks. Multiple warnings covering vascular risks, hyperkalemia potential, liver disease, and hypertension concerns. Contraindicated in females with renal impairment, adrenal insufficiency, thrombotic disease risks, and hepatic disease.
Related Medications
Zotarolimus
zotarolimus
Dosage form: POWDER. Active ingredients: ZOTAROLIMUS (1 g/g). Category: BULK INGREDIENT.
Chromium Chloride
chromium chloride
Dosage form: POWDER. Active ingredients: CHROMIUM (1 g/g). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.
Cidofovir Dihydrate
cidofovir dihydrate
DESCRIPTION The chemical name of cidofovir USP is 1-[( S )-3-hydroxy-2-(phosphonomethoxy)propyl]cytosine dihydrate (HPMPC), with the molecular formula of C 8 H 14 N 3 O 6 P• 2 H 2 O and a molecular weight of 315.22 (279.19 for anhydrous). The chemical structure is: Cidofovir USP is a white crystalline powder with an aqueous solubility of ≥ 170 mg/mL at pH 6 to 8 and a log P (octanol/aqueous buffer, pH 7.1) value of -3.3.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.